Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Radiation Research|October 30, 2007
A novel role for thyroid hormone receptor beta in cellular radiosensitivityMichiko Matsuse, Vladimir Saenko, Ilya Sedliarou, et al.Anticancer Research|January 30, 2008
Overexpression of wild-type THRbeta1 suppresses the growth and invasiveness of human papillary thyroid cancer cellsIlya Sedliarou, Michiko Matsuse, Vladimir Saenko, et al.Mabs|December 20, 2014
Nanocell targeting using engineered bispecific antibodiesKarin Taylor, Christopher B Howard, Martina L Jones, et al.Endocrinology|September 9, 2006
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activationIryna Palona, Hiroyuki Namba, Norisato Mitsutake, et al.International Journal of Oncology|November 18, 2004
The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinomaIlya Sedliarou, Vladimir Saenko, Dmitry Lantsov, et al.Nature Biotechnology|June 30, 2009
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drugJennifer A MacDiarmid, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, et al.Plos One|October 24, 2017
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft modelsMohamed A Alfaleh, Christopher B Howard, Ilya Sedliarou, et al.Frontiers in Oncology|November 10, 2025
Proton boron capture therapy: microdosimetry and treatment planning study with boronSeung Hoon Yoo, Ilya Sedliarou, Jennifer A MacDiarmid, et al.Plos One|April 7, 2016
Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a ModelJennifer A MacDiarmid, Veronika Langova, Dale Bailey, et al.Pageof 1